{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:52:38Z","timestamp":1786989158885,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.fertnstert.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T02:21:50Z","timestamp":1726107710000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Programming the onset of ovarian stimulation: from early follicular phase start to oral contraceptive pill, to luteal phase E2, Duostim, and random start oral contraceptive protocols"],"prefix":"10.1016","volume":"123","author":[{"given":"Sean","family":"Sokteang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichetra","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-8220","authenticated-orcid":false,"given":"Dominique","family":"de Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.09.011_bib1","first-page":"181","article-title":"Follicle stimulating hormone (FSH) as a predictor of decreased oocyte yield in patients with normal anti-M\u00fcllerian hormone (AMH) and antral follicle count (AFC)","volume":"24","author":"Miller","year":"2023","journal-title":"J Reprod Infertil"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.fertnstert.2016.09.013","article-title":"Steroid hormone pretreatments in assisted reproductive technology","volume":"106","author":"Nassar","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0015-0282(16)46390-9","article-title":"The program for in\u00a0vitro fertilization at Norfolk","volume":"38","author":"Jones","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib4","first-page":"169","article-title":"Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotrophin (HMG). I. Separation of FSH and LH by electrophoresis, chromatography and gel filtration procedures","volume":"52","author":"Donini","year":"1966","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)47118-9","article-title":"Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: Phase I \u2013 1981","volume":"39","author":"Wortham","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(78)92957-4","article-title":"Birth after the reimplantation of a human embryo","volume":"2","author":"Steptoe","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0015-0282(16)47536-9","article-title":"Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin\/human chorionic gonadotropin for in\u00a0vitro fertilization","volume":"41","author":"Garcia","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0015-0282(16)31446-7","article-title":"Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses","volume":"4","author":"Noyes","year":"1953","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2010.07.1089","article-title":"Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage","volume":"95","author":"Mart\u00ednez-Burgos","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa1703768","article-title":"IVF transfer of fresh or frozen embryos in women without polycystic ovaries","volume":"378","author":"Vuong","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in\u00a0vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(16)53282-8","article-title":"Gonadotropin suppression with oral contraceptives before in\u00a0vitro fertilization","volume":"53","author":"Gonen","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.fertnstert.2006.11.123","article-title":"Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in\u00a0vitro fertilization","volume":"88","author":"Keltz","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib15","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/humupd\/dmx037","article-title":"GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions","volume":"24","author":"Kolibianakis","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12884-021-03849-8","article-title":"Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders","volume":"21","author":"Xia","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/humupd\/dmac040","article-title":"What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis","volume":"29","author":"Venetis","year":"2023","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/14647273.2023.2175267","article-title":"Comparison of the efficacy of depot GnRH agonist protocol and the GnRH antagonist protocol in patients with repeated IVF failure: a retrospective cohort study","volume":"26","author":"Li","year":"2023","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","article-title":"Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis","volume":"90","author":"Griesinger","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib22","article-title":"Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques","volume":"5","author":"Farquhar","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/humrep\/dez299","article-title":"The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF\/ICSI cycles","volume":"35","author":"Montoya-Botero","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2006.08.098","article-title":"Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment","volume":"87","author":"Bellver","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","article-title":"Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2016.43.4.228","article-title":"Pretreatment of normal responders in fresh in\u00a0vitro fertilization cycles: a comparison of transdermal estradiol and oral contraceptive pills","volume":"43","author":"Pereira","year":"2016","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3892\/etm.2015.2734","article-title":"Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: a pilot perspective study proposal","volume":"10","author":"Gizzo","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2021.09.010","article-title":"Common practices among consistently high-performing in\u00a0vitro fertilization programs in the United States: 10-year update","volume":"117","author":"Knudtson","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib29","first-page":"439","article-title":"Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition","volume":"77","author":"le Nestour","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0015-0282(99)00155-7","article-title":"Programming ovulation in the menstrual cycle by a simple innovative approach: back to the future of assisted reproduction","volume":"72","author":"de Ziegler","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humrep\/13.3.561","article-title":"Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH)","volume":"13","author":"de Ziegler","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-2005-923393","article-title":"Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation","volume":"23","author":"Fanchin","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib34","first-page":"199","article-title":"Estradiol and antagonist pretreatment prior to microdose leuprolide in in\u00a0vitro fertilization. Does it improve IVF outcomes in poor responders as compared to oral contraceptive pill?","volume":"60","author":"Elassar","year":"2015","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2011.07.1138","article-title":"Programming in\u00a0vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?","volume":"96","author":"Guivarc\u2019h-Lev\u00eaque","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/deac081","article-title":"Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial","volume":"37","author":"Zhang","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10815-011-9685-7","article-title":"Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization","volume":"29","author":"Chang","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10815-009-9300-3","article-title":"IVF\/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study","volume":"26","author":"Ye","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2008.04.024","volume":"92","author":"Weitzman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-11-96","article-title":"Cycle scheduling for in\u00a0vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial","volume":"11","author":"Hauzman","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib41","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/humrep\/deae167","article-title":"Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial","volume":"39","author":"C\u00e9drin-Durnerin","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jsbmb.2013.04.007","article-title":"Steroids pretreatment in assisted reproduction cycles","volume":"139","author":"Sobotka","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.fertnstert.2011.06.022","article-title":"Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial","volume":"96","author":"Garcia-Velasco","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2016.04.006","article-title":"Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in\u00a0vitro fertilization or intracytoplasmic sperm injection","volume":"106","author":"Qin","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib46","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/humrep\/deac222","article-title":"Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles","volume":"37","author":"Martinez","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.04.013","article-title":"Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy","volume":"47","author":"Giles","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103639","article-title":"Progestin-primed ovarian stimulation: for whom, when and how?","volume":"48","author":"Ata","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.23736\/S2724-606X.22.05176-4","article-title":"Role and effectiveness of progestins in pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and a meta-analysis","volume":"75","author":"Yildiz","year":"2023","journal-title":"Minerva Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00404-023-07269-1","article-title":"GnRH antagonist protocol versus progestin-primed ovarian stimulation in patients with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"309","author":"Deng","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of fresh versus frozen embryos in ovulatory women","volume":"378","author":"Shi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoad051","article-title":"The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles","volume":"2024","author":"Nie","year":"2024","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in\u00a0vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib58","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib59","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00404-024-07690-0","article-title":"Comparison of fixed and flexible progestin-primed ovarian stimulation in women classified in patient-oriented strategies encompassing individualized oocyte number (POSEIDON) group 4","volume":"310","author":"Matsuda","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib60","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rbmo.2018.12.044","article-title":"Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles","volume":"38","author":"Evans","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib62","first-page":"492","article-title":"Detecting mosaicism in trophectoderm biopsies: current challenges and future possibilities","volume":"32","author":"Capalbo","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib63","unstructured":"Racca A, Rodriguez I, Garcia S, Arroyo G, Polyzos NP. Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh). Hum Reprod. In press."},{"key":"10.1016\/j.fertnstert.2024.09.011_bib64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.rbmo.2014.08.010","article-title":"Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technology is limited","volume":"29","author":"Moffat","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib65","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/humrep\/dead113","article-title":"DuoStim reduces time to pregnancy, minimizes treatment discontinuation, and is potentially cost-effective","volume":"38","author":"Garcia-Velasco","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/humrep\/dead002","article-title":"Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up","volume":"38","author":"Tocci","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib67","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/humrep\/deaa203","article-title":"The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study","volume":"35","author":"Vaiarelli","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-024-03222-6","article-title":"Patient experience of social and medical fertility preservation fully reimbursed in France","author":"Hagege","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GCO.0000000000000180","article-title":"Random-start ovarian stimulation in patients with cancer","volume":"27","author":"Cakmak","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102080","article-title":"Ovarian stimulation for fertility preservation in women with cancer: a systematic review and meta-analysis comparing random and conventional starts","volume":"50","author":"Alexander","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/rmb2.12263","article-title":"Random-start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer","volume":"18","author":"Nakasuji","year":"2019","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humrep\/deac242","article-title":"IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients","volume":"38","author":"Esmaeilian","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103572","article-title":"Random-start ovarian stimulation in an oocyte donation programme: a large, single-centre, experience","volume":"48","author":"Guerrero","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.09.011_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2024.104121","article-title":"The dark side of random-start ovarian stimulation: ovarian hyperstimulation syndrome due to inadvertent pregnancy","volume":"49","author":"Semrl","year":"2024","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224022246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:03:08Z","timestamp":1767229388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224022246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0015028224022246"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.011","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programming the onset of ovarian stimulation: from early follicular phase start to oral contraceptive pill, to luteal phase E2, Duostim, and random start oral contraceptive protocols","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}